(Q33976439)

30 July 2017

Treatment of murine fusariosis with SCH 56592 (English)

1 reference

30 July 2017

M Lozano-Chiu

1

1 reference

30 July 2017

S Arikan

2

1 reference

30 July 2017

V L Paetznick

3

1 reference

30 July 2017

E J Anaissie

4

1 reference

30 July 2017

D Loebenberg

5

1 reference

30 July 2017

J H Rex

6

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

30 July 2017

3

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

30 July 2017

43

1 reference

30 July 2017

3

1 reference

30 July 2017

589-591

1 reference

Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89164

Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89164

Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89164

Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89164

In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89164

Opportunistic fusarial infections in humans

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89164

Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89164

Fusarium infections in immunocompromised patients: case reports and literature review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89164

Taxonomy, biology, and clinical aspects of Fusarium species

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89164

Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89164

Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89164

Fusarium and the immunocompromised host: liaisons dangeureuses

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89164

Lack of activity of amphotericin B in systemic murine fusarial infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89164

A fatal infection due to Fusarium oxysporum in a child with Wilms' tumour. Case report and review of the literature

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89164

Cutaneous infection in man caused by Fusarium moniliforme

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89164

In vitro sensitivity of medically significant Fusarium species to various antimycotics.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89164

In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains

29 October 2018

1 reference

12 December 2020

Extensive subcutaneous hyphomycosis caused by Fusarium oxysporum

1 reference

12 December 2020

The Emerging Role of Fusarium Infections in Patients with Cancer

1 reference

12 December 2020

[Fusarium solani bronchopneumonia in a patient with acute myeloblastic leukemia]

1 reference

12 December 2020

Two cases of exogenous endophthalmitis due to Fusarium moniliforme and Pseudomonas species as associated aetiological agents

1 reference

12 December 2020

Identifiers

0 references

1 reference

30 July 2017

1 reference